Webinar to Explore Vascular Nanomedicine Targeting Strategies for Drug Delivery
TL;DR
BOC Sciences' webinar with Dr. Muzykantov reveals advanced vascular targeting strategies that could provide pharmaceutical companies with competitive advantages in developing more effective drug delivery systems.
The webinar explains how vascular nanomedicine works through cognizant targeting using known binding sites and fortuitous tropism where delivery systems exhibit unexpected homing behaviors to specific vascular targets.
This research advances precision medicine by improving drug delivery efficiency, potentially leading to safer, more effective treatments that enhance patient outcomes and quality of life worldwide.
Discover how fortuitous tropism allows drug delivery systems to unexpectedly home in on vascular targets, revealing nature's surprising pathways for precision medicine breakthroughs.
Found this article helpful?
Share it with your network and spread the knowledge!
The pharmaceutical research community will gain insights into cutting-edge vascular nanomedicine approaches during an upcoming webinar hosted by BOC Sciences. Dr. Vladimir Muzykantov, Founding Co-Director of the PSOM/SEAS Center for Targeted Therapeutics and Translational Nanomedicine at the University of Pennsylvania, will present "Vascular Nano-Delivery Using Tropism and Targeting" on December 12th, 2025. Dr. Muzykantov's presentation will address current knowledge on vascular nanomedicine, focusing on optimization strategies for drug delivery systems to reach specific vascular targets. The session will cover both cognizant targeting approaches based on known binding sites and fortuitous tropism, where delivery systems demonstrate unexpected affinity or homing behaviors toward specific tissues.
The webinar tackles one of pharmaceutical research's most significant challenges: achieving efficient and precise drug delivery. As a leading drug discovery contract development and manufacturing organization, BOC Sciences offers comprehensive solutions for designing, developing, and enhancing critical delivery systems. Their strategies help researchers navigate biological barriers while improving drug bioavailability, safety, stability, and effectiveness. BOC Sciences' expertise in advanced delivery carriers includes liposomes, nanoparticles, and microspheres. The company ensures researchers have access to quality materials and technical support needed to accelerate projects from laboratory development to clinical application. Registration for the virtual event is available through their online platform.
Dr. Muzykantov brings substantial credentials to the discussion, having authored over 330 publications with an h-index of 87. He is widely recognized as a foundational figure in vascular targeting therapies, and his work has established fundamental principles in the field. The webinar represents BOC Sciences' strategic commitment to connecting their community with visionary researchers shaping medicine's future. This collaboration exemplifies how industry and academia can work together to address latest challenges and advancements in pharmaceutical research. The session promises to provide valuable insights that could influence the development of next-generation targeted nanomedicines, potentially transforming how vascular diseases are treated through more precise therapeutic delivery mechanisms.
Curated from 24-7 Press Release
